<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bauer</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Esquilin</surname>
    <given-names>I. O.</given-names>
   </name>
   <name>
    <surname>Cornier</surname>
    <given-names>A. S.</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>S. J.</given-names>
   </name>
   <name>
    <surname>Quintero Del Rio</surname>
    <given-names>A. I.</given-names>
   </name>
   <name>
    <surname>Bertran-Pasarell</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2015</year>). 
  <article-title>A phase II, randomized, safety and immunogenicity trial of a re-derived, live-attenuated dengue virus vaccine in healthy children and adults living in Puerto Rico</article-title>. 
  <source>Am. J. Trop. Med. Hyg.</source>
  <volume>93</volume>, 
  <fpage>441</fpage>â€“
  <lpage>453</lpage>. 
  <pub-id pub-id-type="doi">10.4269/ajtmh.14-0625</pub-id>
  <?supplied-pmid 26175027?>
  <pub-id pub-id-type="pmid">26175027</pub-id>
 </mixed-citation>
</ref>
